222 related articles for article (PubMed ID: 23107657)
1. Porcine circovirus type 2 (PCV2) vaccination reduces PCV2 in a PCV2 and Salmonella enterica serovar Choleraesuis coinfection model.
Takada-Iwao A; Seki M; Nakanishi M; Souma J; Okuda S; Okuda Y; Imai Y; Sato S
Vet Microbiol; 2013 Feb; 162(1):219-23. PubMed ID: 23107657
[TBL] [Abstract][Full Text] [Related]
2. Porcine circovirus type 2 potentiates morbidity of Salmonella enterica serovar Choleraesuis in Cesarean-derived, colostrum-deprived pigs.
Takada-Iwao A; Nakanishi M; Souma J; Chikata S; Okuda Y; Imai Y; Sato S
Vet Microbiol; 2011 Dec; 154(1-2):104-12. PubMed ID: 21782358
[TBL] [Abstract][Full Text] [Related]
3. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
[TBL] [Abstract][Full Text] [Related]
4. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions.
Opriessnig T; Xiao CT; Halbur PG; Gerber PF; Matzinger SR; Meng XJ
Vaccine; 2017 Jan; 35(2):248-254. PubMed ID: 27919634
[TBL] [Abstract][Full Text] [Related]
5. Porcine circovirus type 2 (PCV2) vaccination is effective in reducing disease and PCV2 shedding in semen of boars concurrently infected with PCV2 and Mycoplasma hyopneumoniae.
Opriessnig T; Madson DM; Schalk S; Brockmeier S; Shen HG; Beach NM; Meng XJ; Baker RB; Zanella EL; Halbur PG
Theriogenology; 2011 Jul; 76(2):351-60. PubMed ID: 21496897
[TBL] [Abstract][Full Text] [Related]
6. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ
Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445
[TBL] [Abstract][Full Text] [Related]
7. Experimental infection of 3-week-old conventional colostrum-fed pigs with porcine circovirus type 2 and porcine parvovirus.
Ostanello F; Caprioli A; Di Francesco A; Battilani M; Sala G; Sarli G; Mandrioli L; McNeilly F; Allan GM; Prosperi S
Vet Microbiol; 2005 Jul; 108(3-4):179-86. PubMed ID: 15916871
[TBL] [Abstract][Full Text] [Related]
8. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
[TBL] [Abstract][Full Text] [Related]
9. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
[TBL] [Abstract][Full Text] [Related]
10. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus.
Opriessnig T; Fenaux M; Yu S; Evans RB; Cavanaugh D; Gallup JM; Pallares FJ; Thacker EL; Lager KM; Meng XJ; Halbur PG
Vet Microbiol; 2004 Mar; 98(3-4):209-20. PubMed ID: 15036529
[TBL] [Abstract][Full Text] [Related]
11. A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain.
Opriessnig T; Gerber PF; Xiao CT; Mogler M; Halbur PG
Vaccine; 2014 Jan; 32(2):230-7. PubMed ID: 24269319
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
[TBL] [Abstract][Full Text] [Related]
13. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.
Opriessnig T; Gerber PF; Xiao CT; Halbur PG; Matzinger SR; Meng XJ
Vaccine; 2014 Jul; 32(34):4342-8. PubMed ID: 24929119
[TBL] [Abstract][Full Text] [Related]
14. Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.
Opriessnig T; McKeown NE; Harmon KL; Meng XJ; Halbur PG
Clin Vaccine Immunol; 2006 Aug; 13(8):923-9. PubMed ID: 16893993
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.
Niederwerder MC; Bawa B; Serão NV; Trible BR; Kerrigan MA; Lunney JK; Dekkers JC; Rowland RR
Clin Vaccine Immunol; 2015 Dec; 22(12):1244-54. PubMed ID: 26446422
[TBL] [Abstract][Full Text] [Related]
16. Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus.
Opriessnig T; Yu S; Gallup JM; Evans RB; Fenaux M; Pallares F; Thacker EL; Brockus CW; Ackermann MR; Thomas P; Meng XJ; Halbur PG
Vet Pathol; 2003 Sep; 40(5):521-9. PubMed ID: 12949409
[TBL] [Abstract][Full Text] [Related]
17. Oral vaccination with attenuated Salmonella enterica serovar Typhimurium expressing Cap protein of PCV2 and its immunogenicity in mouse and swine models.
Xu XG; Zhao HN; Zhang Q; Ding L; Li ZC; Li W; Wu HY; Chuang KP; Tong DW; Liu HJ
Vet Microbiol; 2012 Jun; 157(3-4):294-303. PubMed ID: 22326539
[TBL] [Abstract][Full Text] [Related]
18. Effect of vaccination of boars against porcine circovirus type 2 on ejaculate characteristics, serum antibody titers, viremia, and semen virus shedding.
Alberti KA; Estienne MJ; Meng XJ
J Anim Sci; 2011 May; 89(5):1581-7. PubMed ID: 21169515
[TBL] [Abstract][Full Text] [Related]
19. A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein.
Guo LJ; Fu YJ; Huang LP; Wang YP; Wei YW; Wu HL; Liu CM
Vaccine; 2015 Jul; 33(31):3752-7. PubMed ID: 26051516
[TBL] [Abstract][Full Text] [Related]
20. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2.
Opriessnig T; Patterson AR; Elsener J; Meng XJ; Halbur PG
Clin Vaccine Immunol; 2008 Mar; 15(3):397-401. PubMed ID: 18094109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
